Drug Purchases’s analysis for COVID-19 treatment in Rio Grande do Sul

Objective: To evaluate quantities and costs of drug purchases related to COVID-19 treatment by regional governments under the Tribunal de Contas do Estado do Rio Grande do Sul (TCE-RS). Methods: A cross sectional study whose data collection was carried out in accordance with the data registered in...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Natália A. PAIM, Diego GNATTA
Formato:	article
Lenguaje:	EN PT
Publicado:	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde 2021
Materias:	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/4688f368b7254b86b857ad92336eeba5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:4688f368b7254b86b857ad92336eeba5
record_format	dspace
spelling	oai:doaj.org-article:4688f368b7254b86b857ad92336eeba52021-11-28T02:43:23ZDrug Purchases’s analysis for COVID-19 treatment in Rio Grande do Sul10.30968/rbfhss.2021.122.05542179-59242316-7750https://doaj.org/article/4688f368b7254b86b857ad92336eeba52021-04-01T00:00:00Zhttps://www.rbfhss.org.br/sbrafh/article/view/554https://doaj.org/toc/2179-5924https://doaj.org/toc/2316-7750 Objective: To evaluate quantities and costs of drug purchases related to COVID-19 treatment by regional governments under the Tribunal de Contas do Estado do Rio Grande do Sul (TCE-RS). Methods: A cross sectional study whose data collection was carried out in accordance with the data registered in the LicitaCon system of TCE-RS until September 29, 2020. The purchase processes of the pharmaceutical products hydroxychloroquine, chloroquine, ivermectin, nitazoxanide, vitamin D, vitamin C and zinc were analyzed in more detail. Results: There were 5,299 purchase processes registered on LicitaCon. Two hundred and fifty cases contained medications, of which 232 were analyzed, for only these met the study’s inclusion criteria. At least one of the aforementioned pharmaceutical products was found in 142 (61.2%) of the analyzed cases. Resulting in a total amount of $ 661.913,52 for the analyzed processes. The most purchased drug was ivermectin, present in 80 of the acquisitions, adding up to $ 241.794,81. The municipality of Garruchos, with an estimated population of 2,886, spent $ 6,858 per inhabitant for the obtainment of ivermectin, consuming a total of $ 19.796,06. Conclusions: The use of such pharmaceutical products for COVID-19 goes against the current available scientific evidence, the recommendations of WHO, the Rational Use of Medicines and Evidence-Based Health. Natália A. PAIMDiego GNATTASociedade Brasileira de Farmácia Hospitalar e Serviços de SaúdearticlePublic aspects of medicineRA1-1270Pharmacy and materia medicaRS1-441Therapeutics. PharmacologyRM1-950ENPTRevista Brasileira de Farmácia Hospitalar e Serviços de Saúde, Vol 12, Iss 2 (2021)
institution	DOAJ
collection	DOAJ
language	EN PT
topic	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950
spellingShingle	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950 Natália A. PAIM Diego GNATTA Drug Purchases’s analysis for COVID-19 treatment in Rio Grande do Sul
description	Objective: To evaluate quantities and costs of drug purchases related to COVID-19 treatment by regional governments under the Tribunal de Contas do Estado do Rio Grande do Sul (TCE-RS). Methods: A cross sectional study whose data collection was carried out in accordance with the data registered in the LicitaCon system of TCE-RS until September 29, 2020. The purchase processes of the pharmaceutical products hydroxychloroquine, chloroquine, ivermectin, nitazoxanide, vitamin D, vitamin C and zinc were analyzed in more detail. Results: There were 5,299 purchase processes registered on LicitaCon. Two hundred and fifty cases contained medications, of which 232 were analyzed, for only these met the study’s inclusion criteria. At least one of the aforementioned pharmaceutical products was found in 142 (61.2%) of the analyzed cases. Resulting in a total amount of $ 661.913,52 for the analyzed processes. The most purchased drug was ivermectin, present in 80 of the acquisitions, adding up to $ 241.794,81. The municipality of Garruchos, with an estimated population of 2,886, spent $ 6,858 per inhabitant for the obtainment of ivermectin, consuming a total of $ 19.796,06. Conclusions: The use of such pharmaceutical products for COVID-19 goes against the current available scientific evidence, the recommendations of WHO, the Rational Use of Medicines and Evidence-Based Health.
format	article
author	Natália A. PAIM Diego GNATTA
author_facet	Natália A. PAIM Diego GNATTA
author_sort	Natália A. PAIM
title	Drug Purchases’s analysis for COVID-19 treatment in Rio Grande do Sul
title_short	Drug Purchases’s analysis for COVID-19 treatment in Rio Grande do Sul
title_full	Drug Purchases’s analysis for COVID-19 treatment in Rio Grande do Sul
title_fullStr	Drug Purchases’s analysis for COVID-19 treatment in Rio Grande do Sul
title_full_unstemmed	Drug Purchases’s analysis for COVID-19 treatment in Rio Grande do Sul
title_sort	drug purchases’s analysis for covid-19 treatment in rio grande do sul
publisher	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
publishDate	2021
url	https://doaj.org/article/4688f368b7254b86b857ad92336eeba5
work_keys_str_mv	AT nataliaapaim drugpurchasessanalysisforcovid19treatmentinriograndedosul AT diegognatta drugpurchasessanalysisforcovid19treatmentinriograndedosul
_version_	1718408437186953216

Drug Purchases’s analysis for COVID-19 treatment in Rio Grande do Sul

Ejemplares similares